Specifics of motivation of volunteers participating in in a clinical trial of the COVID-19 vaccine
Background. The pandemic coronavirus infection has contributed to the development of effective preventive methods to slow the spread of the virus. Mass vaccination is the only way to protect oneself from infection. The development of drugs, including vaccines, involves clinical trials (CT). The prob...
Main Authors: | Y. D. Belousova, V. V. Rafalsky, E. D. Kislova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Izdatelstvo OKI
2023-03-01
|
Series: | Качественная клиническая практика |
Subjects: | |
Online Access: | https://www.clinvest.ru/jour/article/view/634 |
Similar Items
-
A Clinical Study of the Safety and Tolerability of Live Nasal Vaccines for the Prevention of Pertussis
by: A. Yu. Medkova, et al.
Published: (2021-02-01) -
Development of a Method and a Scheme for the Use of a Live Recombinant Vaccine "GamLPV". Safety and Tolerability of Double Intranasal Vaccination of Healthy Adult Volunteers
by: G. I. Karataev, et al.
Published: (2022-09-01) -
Legal aspects of conducting real-world studies
by: V. V. Sikachev, et al.
Published: (2021-02-01) -
Applying real-world data to support regulatory decision — making in the United States
by: M. A. Borzova, et al.
Published: (2021-04-01) -
PROLOG Study: decreasing cardiovascular disease risk in hypertensive patients by antihypertensive therapy
by: S. A. Shalnova, et al.
Published: (2005-08-01)